Probiotic shows promise for reducing frequency of common cold symptoms
nutraingredients.com,
The randomised, double-blind, placebo-controlled, parallel-group comparative trial, conducted by authors from Japan, concluded: …
The randomised, double-blind, placebo-controlled, parallel-group comparative trial, conducted by authors from Japan, concluded: …
The study, conducted and funded by the beverages company Kirin Holdings Company, Tokyo, assessed the effect of 14 days…
Media Outreach 2021-09-17 Clinical trial confirms Kirin Holdings’ Lactococcus lactis strain Plasma effective against the…
Clinical trial confirms Kirin Holdings’ Lactococcus lactis strain Plasma effective against the cureless and vaccineless virus…
Clinical trial confirms Kirin Holdings’ Lactococcus lactis strain Plasma effective against the cureless and vaccineless virus…
Clinical trial confirms Kirin Holdings’ Lactococcus lactis strain Plasma effective against the cureless and vaccineless virus…
17-Sep-2021 Intellasia | Media OutReach | 9:00 AM Clinical trial confirms Kirin Holdings’ Lactococcus lactis strain Plasma…
Clinical trial confirms Kirin Holdings’ Lactococcus lactis strain Plasma effective against the cureless and vaccineless virus…